Email us : info@waife.com
Management Consulting for Clinical Research

Waife & Associates Adds New Senior Associate in Boston

— Former Millennium executive strengthens W&A depth and increases Informatics expertise.

Needham, MA, February 3, 2014— Waife & Associates, Inc., change management consultants in biopharmaceutical clinical research, announced today it has added a new Senior Associate, Siegbert Kloos, to its staff. Mr. Kloos comes to Waife & Associates, Inc. (W&A) from Millennium: The Takeda Oncology Company, where he was most recently Senior Director, Medical Informatics, Strategy and Operations.  Mr. Kloos brings a deep and expert background in both clinical research and medical informatics, a critical intersection for Waife & Associates’ clients.
Based in Boston, Mr. Kloos has nearly thirty years’ experience in clinical research, beginning as a Research Fellow at the University Hospital in Bonn, Germany, followed by five years at Padcom Clinical Research, a CRO (clinical research organization) and developer of early innovative electronic data capture (EDC) software. For nine years, he worked at F. Hoffmann-La Roche in various Informatics capacities in Palo Alto and Basel, and then as Director of Development Lifecycle Systems at Genentech in South San Francisco. Mr. Kloos joined Millennium in 2008, where he initially designed and implemented the Informatics strategy for all departments in clinical development, including Translational Medicine and Pharmacovigilance in addition to Clinical Operations and Biometrics. Later, he created the Strategic Project Management Office, rebuilt the Medical Finance function, and oversaw Medical Business Operations.

 

“We are very pleased to add Siggi to W&A,” said Ronald S. Waife, President, Waife & Associates, Inc. “He deepens our long expertise in Informatics, which underpins all clinical development improvements. He has directly and successfully contributed to the management of global enterprises, encompassing Japan and China as well as the US and Europe. In addition, his extensive exposure to and involvement in the business side of development operations is the perfect complement to our process engineering focus.”

 

Mr. Kloos has been active in the DIA and ACDM, as well as several inter-company working groups. Mr. Kloos was Chair of the Oracle RDC Focus Group for five years, and the MACRO User Group for four years. He has published more than two dozen papers in scientific journals since 1985.

 

Mr. Kloos earned his MSc in the Medical School of the University of Bonn, and studied Biomedical Engineering at the University of Giessen, Germany.  He has received advanced training at the Harvard and London Business Schools and the Takeda Leadership Institute. He is fully bilingual in English and German.

 

Mr. Kloos can be reached at kloos@waife.com or +1 650 888-1758. To learn more about Waife & Associates, Inc., visit www.waife.com.